Utility of 4-arylidene-3-methyl-1H-pyrazole on Michael addition reactions for biological evaluation

Der Pharma Chemica

Volumn 3, Issue 1, 2011, Pages 31-41

  Sayed, Hayam H ^a   Abbas, Hebat Allah S ^a   Morsi, Eman M H ^a   Flefel, Eman M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antimicrobial activity; Indazole; Pyrazolopyrazole; Pyrazolopyrimidine

Indexed keywords

1,2 PHENYLENEDIAMINE; 1H INDAZOLE 5 CARBOXAMIDE DERIVATIVE; 4 ARYLIDENE 3 METHYL 1H PYRAZOLE DERIVATIVE; AMIDE; BENZODIAZEPINE DERIVATIVE; CHLORAMPHENICOL; FLUCONAZOLE; HYDRAZINE; HYDROXYLAMINE; INDAZOLE DERIVATIVE; OXAZOLONE; PYRAZOLE DERIVATIVE; PYRAZOLONE DERIVATIVE; PYRAZOLOPYRIMIDINE DERIVATIVE; PYRAZOLOTHIAZOLOPYRIMIDINONE DERIVATIVE; PYRIMIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; INFRARED RADIATION; MASS SPECTROMETRY; MICHAEL ADDITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 79952150617     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lee, S. and Seung, B. P. J. Org. Lett. 2009, 11(22), 5214-5217.
2. Berry, D. A.; Wotring, L. L.; Darch, J. C. and Townsend, L. B. Nucleosides, Nucleotides and nucleic Acid, 1994, 13(1), 405-420.
3. Warshakoon, N. C.; Wu, S.; Boyer, A.; Kawamoto, R.; Renock, S.; Xu, K.; Pokross, M.; Evdokimov, A. G.; Zhou, S.; Winter, C.; Walter, R. and Mekel, M. J. Bioorg. & Med. Chem., 2006, 16(21), 5687-5690.
4. Weitzel, K. W.; Wickman, J. M.; Augustin, S. G. and Strom, J. G. Clin Ther, 2000, 22(11), 1254-1267.
5. Yousif, N. M.; God, F. A. and Sayed, H. H., Egypt. J. Pharm. Sci., 1996, 37(1), 145-156.
6. Anderson, J. D.; Cottam, H. B.; Larson, S. B.; Nord, L. D.; Revankar, G. R. and Robins, R. K. J. Heterocycl. Chem. 1990, 27, 439-453.
7. Avila, J. L.; Polegre, M. A.; Avila, A. R. and Robins, K. Comp. Biochem. Physiol. 1986, 83C, 285-289.
8. Bhat, G. A.; Montero, J. L.; Panzica, R. P.; Wotring, L. L. and Townsend, L. B. J. Med. Chem. 1981, 24, 1165-1172.
9. Petrie, C. R.; Cottam, H. B.; McKernan, P. A.; Robins, R. K. and Revankar, G. R. J. Med. Chem. 1985, 28, 1010-1016.
10. Peat, A. J.; Boucheron, J. A.; Dickerson, S. H.; Garrid, O. D.; Mills, W.; Peckham, J.; Preugschat, F.; Smalley, T.; Schweiker, S.; Wilson, J. R.; Waug, T. Y.; Zhou, H. Q. and Thomson, S. A. J. Bioorg. Med. Chem. Lett., 2004, 14 (9) 2121-2125.
11. Ullman, B.; J. Pharm. Research, 1984, 1 (5), 194-203.
12. Dempcy, R. O.; Podymingin, M. A. and Reed, M. W.; Epoch Biosci. Bothell, 2002, 14 950, 1236-1245.
13. Johnson, P. S.; Lin, R.; Johnson, S. G.; Peter, J.; Binnun, E.; Steven, K.; Pandey, N. B. and Sandra, J.; Thiazolopyrimidine kinase inhibitors, USPTO patent: Application 20070185139-class: 514260100.
14. Khalil, Z. H.; Abdel Hafez, A. A. and Ahmed, A. A.; Phosphorus, sulfur and silicon; 1989, 45 (1), 81-93.
15. Sayed, H. H.; Moustafa, A. H.; Yousif, N. M.; Assy, M. G. and Abd El-Halim M. A., Phosphorus, sulfur and silicon; 2008, 183, 2318-2329.
16. Sayed, H. H.; Hashem, A. I.; Yousif, N. M. and El-Sayed, W. A., Arch. Pharm. Lifesci, 2007,340, 315-319.
17. Sayed, H. H. and Ali, M. A., Phosphorus, sulfur and silicon; 2008, 183, 156-167.
18. Hafez, H. N., Abbas, H. S. and El-Gazzar, A. B. A., Acta Pharm. 2008; 58: 359-378
19. El-Gazzar, A. B. A., Hafez, H. N and Abbas, H. S., Eur. Med. Chem., 2009; 44: 4249-4258.
20. Abbas, H. S., El Sayed, W. A. and Fathy, F. N., Eur. Med. Chem., 2010; 45: 973-982.
21. Sayed H. H.; Morsy E. H. and Flefel E. M., Synth. comm., 2010, 40(9), 1360-1370.
22. Vinokurov, V. G.; Zykov, D. A.; Kirsanova, Z. D.; Rozenberg, S. G.; Troitskaya, V. S.; Krasnykh, L. A.; Zagorevskii, V. A.; Klimova, N. V. and Pyatin, B. M., Chem. Heterocyclic Comp., 1991, 27(3), 288-291.
23. Jain, S. R. and Kar, A., Planta Med. 1971; 20, 118-123.